|
KMID : 0388220140210040214
|
|
Journal of the Korean Rheumatism Association
2014 Volume.21 No. 4 p.214 ~ p.218
|
|
|
Pulmonary Cryptococcosis in a Patient with Ankylosing Spondylitis treated with Etanercept
|
|
Lim Chae-Ho
Lee Sang-Heon
Kim Ho-Youn
Kim Wan-Seop
Kang Seong-Hui
Kwon Se-Woong
Kim Ji-Wan
Park Soo-Youn
An Sang-Hee
Yu Hyung-Min
Kim Hae-Rim
|
|
|
Abstract
|
|
|
|
Ankylosing spondylitis (AS) is a chronic inflammatory dis-order, commonly characterized by inflammation of axial skeleton and development of enthesopathies. Tumor ne-crosis factor inhibitors (TNFi) shows good therapeutic re-sponses in AS patients without good response to non-ster-oidal anti-inflammatory drugs. Although TNFi are rela-tively safe for AS patients, serious opportunistic infections, including tuberculosis and fungal infection, could develop. Here, according to our knowledge, we report a first Korean case of pulmonary cryptococcosis in a patient with AS treated with etanercept. A 64 year-old man with AS visited due to a newly appeared pulmonary nodule on a routine chest radiography. He had been administered eta-nercept for 5 months. Histologic findings of the lung nod-ule showed characteristic features of cryptococcosis. Etanercept was discontinued and oral fluconazole was ad-ministrated, as there was no evidence of central nervous system involvement. After 7 months of treatment, chest CT showed an improvement of the pulmonary lesion.
|
|
|
KEYWORD
|
|
|
Ankylosing spondylitis, Pulmonary crypto-coccosis, Etanercept, Tumor necrosis factor inhibitor
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|